Previous studies revealed that the PI3K/Akt pathway can upregulate the secretion of metalloproteinase (MMP)-2 and -9 to enhance the invasion ability of ovarian cancer cells [38]. The gene discussed is AKT1; the disease is ovarian carcinoma.